Dr. Avanzi, an expert in immuno-oncology and adoptive T cell therapy, joined Neogene as Vice President of Clinical Development. Prior to joining Neogene, Dr. Avanzi held a number of positions of increasing responsibility at Kite Pharma, serving most recently as Executive Medical Director, where he supported multiple clinical programs through all stages of development. Dr. Avanzi earned his M.D. at Campinas Medical School (Puc) in Brazil and completed an internal medicine residency and hematology/oncology fellowship at Sao Paulo University. He completed his Ph.D. research at the New York Blood Center/Santa Casa Medical School and a post-doctoral fellowship focusing on CAR-T cells at Memorial Sloan Kettering Cancer Center. He is board certified in hematology/oncology by the Brazilian Society of Hematology.